Abstract
The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived gamma-secretase inhibitors for the potential treatment of Alzheimer's disease is described. (c) 2004 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 2685-2688 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 15 |
Issue number | 10 |
DOIs | |
Publication status | Published - 16 May 2005 |
Keywords
- ALZHEIMERS-DISEASE